Todd Asset Management LLC Has $21.87 Million Holdings in McKesson Co. (NYSE:MCK)

Todd Asset Management LLC decreased its position in McKesson Co. (NYSE:MCK) by 6.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 47,240 shares of the company’s stock after selling 3,511 shares during the period. Todd Asset Management LLC’s holdings in McKesson were worth $21,871,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. OFI Invest Asset Management bought a new stake in shares of McKesson during the 3rd quarter valued at about $26,000. Legacy Financial Group LLC bought a new position in shares of McKesson during the 3rd quarter worth approximately $27,000. BKM Wealth Management LLC acquired a new stake in shares of McKesson during the 4th quarter worth approximately $31,000. WASHINGTON TRUST Co increased its stake in shares of McKesson by 42.5% in the 4th quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock valued at $53,000 after acquiring an additional 34 shares in the last quarter. Finally, Milestone Investment Advisors LLC acquired a new position in shares of McKesson during the 3rd quarter valued at $61,000. Institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other McKesson news, EVP Leann B. Smith sold 186 shares of the firm’s stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the transaction, the executive vice president now owns 1,511 shares in the company, valued at approximately $749,456. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other McKesson news, EVP Leann B. Smith sold 186 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total value of $92,256.00. Following the sale, the executive vice president now directly owns 1,511 shares in the company, valued at approximately $749,456. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Brian S. Tyler sold 3,473 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the transaction, the chief executive officer now directly owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The disclosure for this sale can be found here. 0.21% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on MCK shares. Morgan Stanley boosted their price objective on McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Leerink Partnrs reissued an “outperform” rating on shares of McKesson in a report on Monday, February 26th. SVB Leerink started coverage on McKesson in a report on Monday, February 26th. They issued an “outperform” rating and a $600.00 target price on the stock. StockNews.com raised McKesson from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, Mizuho increased their price target on McKesson from $450.00 to $505.00 and gave the company a “neutral” rating in a research report on Friday, February 9th. Two equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, McKesson presently has an average rating of “Moderate Buy” and an average target price of $536.71.

McKesson Stock Performance

MCK stock traded down $1.41 during mid-day trading on Friday, hitting $528.86. The company had a trading volume of 866,981 shares, compared to its average volume of 626,262. The firm has a market cap of $69.50 billion, a PE ratio of 23.96, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45. McKesson Co. has a 12 month low of $352.34 and a 12 month high of $544.81. The stock’s fifty day moving average price is $530.38 and its two-hundred day moving average price is $492.08.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $7.74 EPS for the quarter, beating the consensus estimate of $7.05 by $0.69. McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The business had revenue of $80.90 billion for the quarter, compared to the consensus estimate of $77.93 billion. During the same quarter in the prior year, the business earned $6.90 earnings per share. McKesson’s revenue for the quarter was up 14.8% on a year-over-year basis. Equities analysts anticipate that McKesson Co. will post 27.59 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be paid a dividend of $0.62 per share. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.47%. The ex-dividend date is Friday, May 31st. McKesson’s payout ratio is currently 11.24%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.